Ochsner’s Cardiomyopathy and Heart Transplant Program is the largest Medicare-approved heart transplant program in Louisiana, performing over 20 heart transplants per year. It is also Louisiana’s only pediatric heart transplant program.
Why have a heart transplant at the Ochsner Multi-Organ Transplant Institute?
- Ochsner heart transplant patients have better survival rates better than the national rate.
- The first heart transplant in the Gulf South region performed at Ochsner in 1970.
- Ochsner is nationally-ranked as high performing by U.S. News and World Report for Cardiology and Heart Surgery.
- Ochsner is the state’s largest Medicare-approved heart transplant program and a Center of Excellence for many insurers.
- Shorter hospital stay gets you home sooner
- The only pediatric heart transplant program in Louisiana
- Ochsner remains one of the nation's most experienced and active heart transplant programs conducting more than 20 heart transplants per year.
- Ochsner has performed more than 844 heart transplants.
- An interdisciplinary team approach offers patients comprehensive, coordinated care.
Recognizing that heart failure disease requires a multi-faceted approach, our inter-disciplinary team of cardiovascular surgeons, transplant cardiologists, nurse practitioners, physician assistants, transplant coordinators, social workers, financial coordinators, pharmacists and dieticians work together to provide patients a wide array of innovative technologies in the treatment armamentarium for the whole spectrum of heart failure continuum from early stages to end stages of the disease.
We perform state-of-the-art pharmacological, electrophysiological and surgical interventions such as intravenous inotropic and diuretic therapy in our outpatient infusion suite, ultrafiltration (Aquadex) therapy, bi-ventricular pacing and high risk surgical procedures that includes left ventricular assist devices. Our goal is to provide each patient a tailored plan of treatment addressing their physical, mental and emotional needs with nurse-led clinics, telemanagement, nutrition counseling and social services.
Mechanical Circulatory Support
Ochsner offers patients waiting for heart transplants the Mechanical Circulatory Support program as a bridge to heart transplantation and destination therapy to extend a patient's life.
Left Ventricular Assist Devices (LVADs)
Ochsner offers patients the latest life-extending technology, the HEART MATE II LVAD (left ventricular assist device) as a Food & Drug Administration (FDA) – approved bridge to transplantation. This allows patients to wait in the comfort of their homes for their transplant instead of in the hospital. Ochsner was one of just twenty centers designated as a "Center for Destination Therapy" for the Heartmate I ventricular assist device (VAD). Since that time, our cardiovascular surgeons have participated in research trials for the Jarvik and Micro-med VAD.
When a donor heart is not immediately available, the SynCardia temporary Total Artificial Heart may be an option as a bridge to transplant for patients. The John Ochsner Heart and Vascular Institute is the first in the Gulf South region and one of only 53 certified centers in the U.S. to offer the SynCardia temporary Total Artificial Heart, the world’s first and only FDA-approved total artificial heart.